Lonza Group (OTCMKTS:LZAGY) Sees Strong Trading Volume – Time to Buy?

Shares of Lonza Group Ag (OTCMKTS:LZAGY) saw unusually-strong trading volume on Friday . Approximately 106,022 shares changed hands during trading, an increase of 31% from the previous session’s volume of 80,695 shares.The stock last traded at $66.9675 and had previously closed at $66.26.

Analysts Set New Price Targets

Separately, Zacks Research upgraded shares of Lonza Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, April 8th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Lonza Group Stock Up 1.3%

The stock has a 50-day moving average price of $65.54 and a 200-day moving average price of $65.62. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.24.

About Lonza Group

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.